Compared with ALK expression, neither the expression of p-AKT, p-mTOR, p-4E-BP1, nor p-p70S6K1 had statistically significant differences regarding the median survival time and the 5-year survival rate in the ALCL patients. The gene discussed is RPS6KB1; the disease is anaplastic large cell lymphoma.